???global.info.a_carregar???
Sofia Moreira holds a bachelor’s degree in Biochemistry and a master’s degree in Biopharmaceutical Biotechnology, both from the University of Coimbra. Since 2018, she is a PhD candidate in the doctoral program in Bioengineering – Cell Therapies and Regenerative Medicine. Sofia is developing her work at iBET (Instituto de Biologia Experimental e Tecnológica) where she is focused on establishing scalable and GMP compatible purification processes for Lentiviral Vector in high-throughput manner.
Identification

Personal identification

Full name
Ana Sofia Moreira

Citation names

  • Moreira, AnaS

Author identifiers

Ciência ID
9D14-7DF1-D493
ORCID iD
0000-0003-4448-6375

Email addresses

  • asofiamoreira92@gmail.com (Professional)
  • amoreira@itqb.unl.pt (Professional)
  • asofiamoreira92@gmail.com (Personal)

Addresses

  • IBET - Instituto de Biologia Experimental e Tecnológica. Avenida da República, Estação Agronómica Nacional, 2780-157, Oeiras, Oeiras, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Medical Biotechnology - Gene-based Diagnostics and Therapeutic Interventions
  • Engineering and Technology - Industrial Biotechnology - Bioprocessing Technologies
  • Medical and Health Sciences - Medical Biotechnology - Biomaterials
  • Engineering and Technology - Chemical Engineering - Chemical Process Engineering

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Upper intermediate (B2) Advanced (C1) Upper intermediate (B2) Advanced (C1)
Spanish; Castilian Beginner (A1) Intermediate (B1) Beginner (A1) Beginner (A1)
Education
Degree Classification
2018/02/01 - 2022/02
Ongoing
Program in Bioengineering (Doutoramento)
Major in Cell Therapies and Regenerative Medicine
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
"Accelerating Lentivirus manufacturing: an engineering driven approach" (THESIS/DISSERTATION)
2020/06 - 2020/07
Concluded
PROJECT MANAGEMENT COURSE (Curso de Especialização Tecnológica)
Universidade Nova de Lisboa, Portugal
18/20
2016
Concluded
Mestrado de Biotecnologia Farmacêutica (Mestrado)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Downstream process development of novel valuable bio-therapeutics (19/20)" (THESIS/DISSERTATION)
18/20
2014
Concluded
Bioquímica (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"n/a" (THESIS/DISSERTATION)
14/20
Affiliation

Others

Category
Host institution
Employer
2017/03/01 - 2018/01/31 Junior Research Fellow “Understanding primary hyperoxaluria type 1 towards the development of innovative therapeutic strategies” (Ref. Projeto E-Rare3/0002/2015) Instituto de Biologia Experimental e Tecnológica, Portugal
2016/06/01 - 2017/02/01 Junior Research Fellow "INNOVATE - Identificação de novos bioterapêuticos e desenvolvimento de sistemas de expressão" (Ref. Projeto ERA-IB-2/007/2013) Instituto de Biologia Experimental e Tecnológica, Portugal
Outputs

Publications

Journal article
  1. "Nanoencapsulation of Gla-Rich Protein (GRP) as a Novel Approach to Target Inflammation.". International journal of molecular sciences (2022): https://europepmc.org/articles/PMC9099757.
    10.3390/ijms23094813
  2. Moreira, A.S.; Faria, T.Q.; Oliveira, J.G.; Kavara, A.; Schofield, M.; Sanderson, T.; Collins, M.; et al. "Enhancing the purification of Lentiviral vectors for clinical applications". Separation and Purification Technology 274 (2021): 118598. http://dx.doi.org/10.1016/j.seppur.2021.118598.
    10.1016/j.seppur.2021.118598
  3. Moreira, A.S.; Cavaco, D.G.; Faria, T.Q.; Alves, P.M.; Carrondo, M.J.T.; Peixoto, C.. "Advances in Lentivirus Purification". Biotechnology Journal 16 1 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85097279265&partnerID=MN8TOARS.
    10.1002/biot.202000019
  4. Moleirinho, M.G.; Feast, S.; Moreira, A.S.; Silva, R.J.S.; Alves, P.M.; Carrondo, M.J.T.; Huber, T.; Fee, C.; Peixoto, C.. "3D-printed ordered bed structures for chromatographic purification of enveloped and non-enveloped viral particles". Separation and Purification Technology 254 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85090422558&partnerID=MN8TOARS.
    10.1016/j.seppur.2020.117681
  5. Moreira, A.S.; Silva, A.C.; Sousa, M.F.Q.; Hagner-McWhirterc, Å.; Ahlénc, G.; Lundgren, M.; Coroadinha, A.S.; et al. "Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus". Biotechnology Journal 15 4 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85078774814&partnerID=MN8TOARS.
    10.1002/biot.201900411
  6. Silva, R.J.S.; Moleirinho, M.G.; Moreira, A.S.; Xenopoulos, A.; Alves, P.M.; Carrondo; Peixoto, C.. "A flow-through chromatographic strategy for hepatitis c virus-like particles purification". Processes 8 1 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85079042351&partnerID=MN8TOARS.
    10.3390/pr8010085
  7. Carvalho, S.B.; Silva, R.J.S.; Moreira, A.S.; Cunha, B.; Clemente, J.J.; Alves, P.M.; Carrondo, M.J.T.; Xenopoulos, A.; Peixoto, C.. "Efficient filtration strategies for the clarification of influenza virus-like particles derived from insect cells". Separation and Purification Technology 218 (2019): 81-88. http://www.scopus.com/inward/record.url?eid=2-s2.0-85062000735&partnerID=MN8TOARS.
    10.1016/j.seppur.2019.02.040
  8. Carvalho, S.B.; Silva, R.J.S.; Moleirinho, M.G.; Cunha, B.; Moreira, A.S.; Xenopoulos, A.; Alves, P.M.; Carrondo, M.J.T.; Peixoto, C.. "Membrane-Based Approach for the Downstream Processing of Influenza Virus-Like Particles". Biotechnology Journal 14 8 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85069877680&partnerID=MN8TOARS.
    10.1002/biot.201800570
  9. Carvalho, S.B.; Moreira, A.S.; Gomes, J.; Carrondo, M.J.T.; Thornton, D.J.; Alves, P.M.; Costa, J.; Peixoto, C.. "A detection and quantification label-free tool to speed up downstream processing of model mucins". PLoS ONE 13 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85040242832&partnerID=MN8TOARS.
    10.1371/journal.pone.0190974